Clinical Trials Browser

Phase 2 × OTHER_GOV × Platinum Compounds × Clear all

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Phase 2 Unknown

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT05675033 2023-01-09

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

Phase 2 Unknown

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung